Summary
This study was concerned with the detailed identification of the second product involved in the riboflavin synthetase reaction with riboflavin synthetase from Eremothecium ashbyii and a trapping agent, glyoxal. Thus, a green fluorescent compound accumulated during the incubation. The compound was purified through various column chromatography steps, and was examined by UV, IR, excitation and emission spectra and paper chromatography to prove that the isolated compound was 8-ribityllumazine. Accordingly it was concluded that a second product in riboflavin synthetase reaction was 4-ribitylamino-5
amino-2, 6-dihydroxypyrimidine, the fragment, except for C-6 and C-7 of 8-ribityllumazine, being an incorporated glyoxal portion.
Riboflavin synthetase (EC 2. 5. 1. 9), which catalyzes the conversion of 6, 7 -dimethyl-8-ribityllumazine to riboflavin, has been detected in many organisms (1) (2) (3) (4) . Furthermore, it has been clarified that the substrates in the reaction are only two molecules of 6, 7-dimethyl-8-ribityllumazine, one of which is the donor and another the accepter of 4-carbon, which is the building block of the o-xylene ring of the riboflavin molecule (1, 5, 6) . Accordingly, it is easily supposed that the fragment, except for 4-carbon portion of 6, 7-dimethyl-8-ribityllumazine, 4-ribitylamino-5-amino-2, 6-dihydroxypyrimidine, can be one of the reaction products. WAOHER et al. (7) detected this compound in the form of 8-ribityl lumazine, using a trapping agent, glyoxal, in the reaction mixture with ribo fl avin synthetase from Ashbya gossypii. But, identification of the isolated com pound was not carried out in detail. Thereafter, the trial was not done in this field.
In the present paper, the authors tried to elucidate the structure of the by product in detail using riboflavin synthetase from Eremothecium ashbyii. 
RESULTS
1. Paper chromatographic and fluorometric analyses of the purified green fluores cent compound For identification of the purified green fluorescent compound, paper partition chromatography was done in various organic solvents as seen in Table 1 . The isolated compound was localized as a single fluorescent spot under ultraviolet light on the paper chromatograms. The results show that the Rf values of isolated compound are the same as those of synthesized 8-ribityllumazine in these solvents. 
Spectrophotometric analyses of the purified green fluorescent compound
Ultraviolet and visible light absorption spectra of the isolated compound and synthesized 8-ribityllumazine were determined at wavelengths ranging from 240 to 500 nm in acid and alkali solutions (Fig. 2) . Maximum absorptions were observed at 258, 277 (shoulder) and 400 nm in 0.1 N HCl and at 281 and 312 nm in 0.1 N NaOH, in which the maximum absorption seen near 400 nm in acid solution is a characteristic of 8-ribitylpteridine derivatives.
Infrared absorption spectra of isolated compound and synthesized 8-ribityl lumazine were determined with KBr pellet method, and the results were given in Fig. 3 . As seen in this figure, there is a clear-cut correspondence between the isolated compound and synthesized 8-ribityllumazine. 
DISCUSSION
The present authors have shown that only two molecules of 6, 7-dimethyl -8-ribityllumazine are obligatory as substrate for riboflavin synthetase reaction and no other compounds, such as 4-carbon derivatives, are needed with ribo fl avin synthetase from spinach leaves (1) . Thereafter, the reaction mechanism, in which one of the substrates is a 4-carbon donor and another is an accepter in the formation of riboflavin skeleton, was verified by works with labelled 6, 7 dimethyl-8-ribityllumazine using enzymes from A. gossypii (5) and yeast (6) . It thus follows that one of the reaction products is riboflavin and most probably another is 4-ribitylamino-5-amino-2, 6-dihydroxypyrimidine, based on the structure of produced riboflavin molecule. Plaut tried to identify the structure of the latter compound by degradation experiments (10) using an isolated compound and experiments (7) with reference compounds, and proposed that the compound is 4-ribitylamino-5-amino-2, 6-dihydroxypyrimidine which was isolated as 8-ribityl lumazine after being trapped by glyoxal. However, the isolation and purification T. NADAMOTO, and K. NAKAJIMA Fig. 4 . Proposed scheme of the recyclization of the second product in the riboflavin synthetase reaction. of the second product was not carried out in detail.
The results given in the present paper clearly indicate that another reaction product, a by-product, in the riboflavin synthetase reaction is 4-ribitylamino-5 amino-2, 6-dihydroxypyrimidine, being a pyrimidine portion of isolated 8-ribityl lumazine. Previously, we isolated 4-ribitylamino-5-amino-2, 6-dihydroxypy rimidine as an immediate intermediate of 6, 7-dimethyl-8-ribityllumazine from non growing cells of high flavinogenic mold, E. ashbyii, in the form of 8-ribityllumazine by using glyoxal as a trapping agent (11) . Accordingly, the by-product was concluded to be completely identical with the immediate precursor of 6, 7-dimethyl 8-ribityllumazine in the structure of 4-ribitylamino-5-amino-2, 6-dihydroxypy rimidine. This easily indicates that the by-product bound with suitable building blocks, needed for the formation of pyrazine ring of 6, 7-dimethyl-8-ribityllumazine, can be reutilized for the in vivo synthesis of riboflavin. The possibility was clearly elucidated in vitro by works (8) with riboflavin synthetase from E, ashbyii, in which diacetyl rather than acetoin was used as an efficient building block for the formation of 6, 7-dimethyl-8-ribityllumazine. Thus, we proposed that a recyclization of the by-product proceeds through the riboflavin synthetase reaction by supple mentation of suitable 4-carbon such as diacetyl in cells. This mechanism is de picted in Fig. 4 , although the actual 4-carbon compound in cells is equivocal.
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